Literature DB >> 3554091

Survival of corneal grafts from donors supported by mechanical ventilation.

J A Seedor, R D Stulting, R J Epstein, R E Nay, N G Dreizen, G O Waring, L A Wilson, H D Cavanagh.   

Abstract

Eighty-five patients undergoing penetrating keratoplasty with tissue from donors supported by mechanical ventilation (Ventilator group) were compared to a surgeon- and diagnosis-matched group (Control group). Age at surgery, duration of follow-up, and sex of recipient patients were similar in the two groups. The mean donor age in the Ventilator group (26.4 years) was significantly less than in the Control group (45.8 years, P less than 0.0001). Mean time on the ventilator was 99.4 hours (range, 4 hours to 21 days). Overall graft survival rates in the Ventilator and Control groups were similar (P greater than or equal to 0.72). Time on the ventilator did not affect graft survival. Cultures of corneoscleral donor rims were positive more often in the Ventilator group than in Controls (39.7 versus 23.1%), but the difference was not significant (P = 0.09). Prolonged ventilator time was not associated with a higher rate of positive corneoscleral rim cultures, nor did positive cultures affect graft survival. The most common cause of graft failure in both groups was allograft rejection. In no case could postoperative bacterial infection be attributed to contamination of the donor material. One case of primary donor failure occurred in the Ventilator group, but the incidence (1.2%) is similar to that of previously reported studies. The data indicate that corneal tissue from ventilator-supported donors should be considered for use in penetrating keratoplasty.

Entities:  

Mesh:

Year:  1987        PMID: 3554091     DOI: 10.1016/s0161-6420(87)33490-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  1 in total

1.  Therapeutic dilemma in fungal keratitis: administration of steroids for immune rejection early after keratoplasty.

Authors:  Ting Wang; Suxia Li; Hua Gao; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-24       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.